BIIB - no, none of those things apply to BIIB. They have excellent earnings, and they are a "deep-pocket" competitor in the biotech-pharma-drug-development game. (Giants like Merck, J&J, et alia. have been Resting-In-Place for a decade; they are buying drugs, not inventing them.) (Which works just fine for them. Wouldn't be shocked to see BIIB acquired)
Speaking of which, BIIB is still a big gainer for me since Cramer got me interested three years ago. Luckily I took profits in December on most of it. IMO the haircut of -25% was overdone for an earnings estimate revision of about -6%, so I rebought last week at 302 and 307. They have a strong pipeline and a great track record.
The selling will never end. Ha! Too bad the shareholders couldn't vote on the 55 billion dollar msft buyout.
MSFT wouldn't do that. It would be as though a stable company had bought ENRON at it's peak. Even if MSFT wants parts of CRM (and I'm not saying they want any of it), they would likely wait to buy it closer to half the price you wrote.
Have you wondered why on the CRM site there are more pr pieces and errors about former prints than there are on sites of other stocks?
Earlier today I took profits on some shorts from late last week so any report that CRM could go up doesn't bother me. Though I'm not surprised by inaccurate comments about CRM, I'm calling attention to former prints. Asking for a price can be different from a printed price.
Isn't that what was insisted about other companies from BIIB last week and too many other stocks to mention.
yes, what a wacky rationale for buying: i expect the price to go up after a huge earnings beat.
Salesforce consistently defeats deep-pocket competitors, but u say they "can't". More accurate to say that you do not understand what is actually happening before your eyes.
Wow. You provide such a great rationale for buying CRM..... counting on MB to pull a rabbit from the hat.
AMZN provides services to a much wider audience and the competitors are vast and often weak brick and mortar stores. CRM's main competitors are companies with cash and able to strengthen their abilities. Main competitors or CRM have bought companies with cash. CRM can't compete with deep pocket companies. When CRM drops far enough, perhaps there will be an acquisition at a much lower price.
"Amazing" CRM reminds some of a once high flying stock that has been delisted.
Please note that another "buy" rating has been removed.
In the newer market atmosphere, real delivery wins over pumps and promises.
so, amazon said they would attend to their margins. A little while later, Shazam! (for those who read this forum but not the headlines: amzn 16% today )
Sounds like CRM. Who knows when, but do not doubt it: CRM will pull a similar rabbit from the hat in an upcoming quarter.
Add to that, the date of the quarterly report has been altered and is now listed as being within a range of days. Is that in case they need extra days to prepare the report?
We've seen this before: a Friday pump following insider selling earlier this week and selling likely into today's bounce. CRM has turned even more bearish as another buy order has dropped out. There are twice as many sells than buys and that's in addition to the neutral rating which some prefer to use instead of "sell."
I think MSFT shareholders would storm company HQ if officials bought this money losing company for $85 per share.